Rockwell Automation launches PharmaSuite 12.01. Latest release simplifies recipe maintenance, enhances traceability and helps manufacturers standardize production processes across sites. FactoryTalk(R) PharmaSuite(R) 12.01.00 is the latest release of Rockwell's manufacturing execution system (MES), designed to support the unique needs of regulated pharmaceutical and biopharmaceutical manufacturing environments. Building on the containerized architecture introduced in PharmaSuite 12.00, the new release delivers enhanced recipe lifecycle management, expanded workflow capabilities and improved operational efficiency to help life sciences companies reduce maintenance effort, accelerate scale-up and simplify ongoing system management. More headlines. Articles. As pharmaceutical manufacturers continue to pursue greater agility, standardization and digitalization across global production networks, they face increasing pressure to manage manufacturing complexity, maintain compliance and minimize operational disruptions. PharmaSuite 12.01 addresses these challenges with new capabilities that simplify recipe maintenance, enhance traceability and help manufacturers standardize production processes across sites. The release introduces a new recipe lifecycle management framework designed to significantly simplify maintaining and upgrading manufacturing recipes and workflows. Additional workflow enhancements provide more flexible material tracking, helping manufacturers accelerate deployment of new processes while maintaining regulatory compliance and operational consistency. PharmaSuite 12.01 also includes platform updates, security enhancements and continued optimization of Kubernetes-based deployments to improve scalability, maintainability and operational reliability. FactoryTalk PharmaSuite 12.01 continues the commitment Rockwell Automation has made to help pharmaceutical and biopharmaceutical manufacturers modernize operations while maintaining the highest standards of quality, compliance and data integrity. By combining containerized deployment, automated lifecycle management and workflow-driven manufacturing, PharmaSuite 12.01 helps organizations accelerate digital transformation, standardize manufacturing operations and reduce the effort required to maintain and evolve the MES landscape.

Rockwell Automation chief executive Blake Moret bought about $1.55 million of the company's stock on Monday, two trading days after shares fell 14.15% in one session. He bought 4,000 shares at a weighted average of $386.36 through his family trust. It is only his second open-market purchase. The drop followed fiscal fourth-quarter sales of $2.3 billion, short of the $2.41 billion consensus. An $85 million accrual for tariff refunds to customers caused the miss, while adjusted earnings per share rose 16% to $3.88, beating the $3.69 estimate. Rockwell guided to fiscal 2027 organic growth of 6% to 9%. His only earlier buy, 3,500 shares at $283.65 in January 2024, is up 37.3% on price alone.

Rockwell Automation has launched PanelView Pro, a graphic terminal for demanding industrial settings. The device is built for FactoryTalk View Machine Edition (ME) applications and lets manufacturers keep their existing software while moving to new hardware. Its modular design separates display and logic components, so customers can replace single modules instead of a whole terminal. Rockwell says this cuts maintenance costs and improves system availability. The terminal also runs on a managed operating system with secure remote access. It supports application reuse and common cutouts, easing migration from PanelView Plus 7 Performance terminals with less downtime. PanelView Pro will be available from the fourth quarter of 2026, with more modular components and configurations arriving throughout 2027.